Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Certified Pharmacy Executive Leader

Digital Health & Informatics

Diversity, Equity and Inclusion

Health & Wellness

Opioids & Pain Management

Sterile Compounding

73 Views

Resident Poster

(9-339) Medication Use Evaluation of Tirzepatide FDA Approved for Type 2 Diabetes in the Outpatient Setting

Wednesday, December 11, 2024

8:30 AM – 9:30 AM

Location: Hall G, Lower Level

Category: Evaluative Study
Topic: Ambulatory Care

Co-Author(s): Sheerida Hosein Mohammed, Faaria Quadri, Emilie Collongette

Primary Author(s)